跳至主要内容
临床试验/NCT01407289
NCT01407289已完成4 期

An Open, Single-centre, Controlled Trial to Investigate the Efficacy and Usability of Published Best Practice to Control Glycaemia in Hospitalised Patients With Type 2 Diabetes

Medical University of Graz1 个研究点 分布在 1 个国家目标入组 74 人开始时间: 2011年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
74
试验地点
1
主要终点
Mean blood glucose

研究概览

简要总结

The purpose of the study is to compare the efficacy of enhanced published best practice paper-based insulin titration protocol for glycaemic control in hospitalised patients with type 2 diabetes for the length of hospital stay.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Type 2 diabetes
  • Blood glucose in the range between 140 - 400 mg/dl
  • Expected stay ≥ 48 hours

排除标准

  • Hyperglycemia without known history of type 2 diabetes mellitus
  • Impaired renal function (serum creatinine ≥3.0mg/dL)
  • Clinically relevant hepatic disease

研究组 & 干预措施

Insulin titration protocol

Experimental

Patients in care at the Division of Endocrinology will be treated by enhanced version of published best paper based practice insulin titration protocol to control glycaemia in hospitalised patients with type 2 diabetes.

干预措施: Insulin Aspart, Insulin Glargine (Drug)

结局指标

主要结局

Mean blood glucose

时间窗: duration of hospital stay (48 hours - maximum three weeks)

Mean blood glucose over 24 hours

次要结局

  • Number of glucose measurements in hyperglycaemic ranges(duration of hospital stay (48 hours - maximum three weeks))

研究者

发起方
Medical University of Graz
申办方类型
Other
责任方
Principal Investigator
主要研究者

Pieber Thomas, MD

MD, Prof. of Medicine

Medical University of Graz

研究点 (1)

Loading locations...

相似试验